
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CUL-4A CRISPR/Cas9 KO Plasmid (h) | sc-401967 | 20 µg | $397.00 |
CUL4A encodes cullin-4A, a core scaffold of the CRL4 E3 ubiquitin ligase complex that coordinates ubiquitination and proteasomal turnover of proteins governing DNA replication, chromatin dynamics, and cell-cycle progression. By partnering with adaptor proteins such as DDB1 and multiple DCAF substrate receptors, CUL-4A regulates processes including nucleotide excision repair, replication licensing, and responses to UV-induced DNA damage. Disruption of CUL4A-dependent proteostasis can perturb genome stability and checkpoint control, linking altered CRL4 activity to cancer-associated phenotypes and other disorders involving defective DNA repair. As a central node in ubiquitin-mediated signaling, CUL-4A is frequently studied in pathways that couple chromatin regulation to replication stress and transcriptional control.
CUL-4A CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the CUL4A gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the CUL4A together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the CUL4A open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish CUL-4A protein expression.
This CRISPR knockout system enables efficient generation of CUL4A-deficient cell models for investigation of CUL-4A signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.